Executive Committee

John C. Lechleiter, Ph.D.

John C. Lechleiter, Ph.D.

Chairman, President, and Chief Executive Officer


John Lechleiter has served as president and chief executive officer of Eli Lilly and Company since April 1, 2008. He became chairman of the board of directors on January 1, 2009.

John joined Lilly in 1979 as a senior organic chemist in process research and development and became head of that department in 1982. In 1984, he began serving as director of pharmaceutical product development for the Lilly Research Centre Limited in Windlesham, England. He later held roles in project management, regulatory affairs, product development, and pharma operations. In 2005, he was named president and chief operating officer and joined the board of directors.

John earned a bachelor’s degree in chemistry from Xavier University and master’s and doctoral degrees in organic chemistry from Harvard University. John has received honorary doctorates from Marian University (Indianapolis, Indiana), the University of Indianapolis, the National University of Ireland, Indiana University, and Franklin College.

Lechleiter is a member of the American Chemical Society and Business Roundtable. He serves on the board of the Pharmaceutical Research and Manufacturers of America (PhRMA), as president of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), as chairman of the U.S.-Japan Business Council and of United Way Worldwide, and on the boards of the Life Sciences Foundation, and the Central Indiana Corporate Partnership. He also serves on the boards of Nike, Inc. and Ford Motor Company.

show morePrint Bio
Melissa Stapleton Barnes

Melissa Stapleton Barnes

Senior Vice President, Enterprise Risk Management,

and Chief Ethics and Compliance Officer


Melissa Stapleton Barnes is senior vice president, enterprise risk management, and chief ethics and compliance officer for Eli Lilly and Company.

Melissa joined Lilly in 1994 and has held a variety of business and legal roles, including general counsel for Lilly Diabetes and Lilly Oncology, managed market segment leader for national accounts, and Six Sigma black belt. Prior to taking her current role in 2013, she was vice president and deputy general counsel, global litigation and specialty legal. In this capacity, she was responsible for overseeing the company’s global litigation and investigations, as well as managing the corporate secretary’s office and specialty legal functions.

Before joining Lilly, Melissa was a litigator for the law firm of Baker & Daniels in Indianapolis.

Melissa earned a Bachelor of Science with highest distinction from Purdue University and a law degree from Harvard Law School.

In 2012, Melissa was recognized by the Healthcare Businesswomen’s Association as a “Rising Star.” She currently serves on the board and executive committees of The Center for Performing Arts and is a board member of Visit Indy. She is also a member of the executive committee for Carmel Young Life.

show morePrint Bio
Enrique A. Conterno

Enrique A. Conterno

Senior Vice President and President, Lilly Diabetes


Enrique Conterno is a senior vice president of Eli Lilly and Company and president of Lilly Diabetes.

Enrique joined Lilly in 1992 and has held a range of roles in sales, finance, marketing, business development, and general management. He served as marketing and sales director for Lilly’s Peru and Brazil affiliates, as executive marketing director for the intercontinental region and Japan, and as general manager for Lilly Mexico. Enrique was vice president of the company’s U.S. neuroscience business unit and vice president for health care professional markets. He served as president of Lilly’s U.S. affiliate until he was named president of Lilly Diabetes in 2009.

Enrique earned a bachelor’s degree in mechanical engineering from Case Western Reserve University and a master’s degree in business administration from Duke University.

He serves on the board of the National Association of Manufacturers (NAM) and as treasurer for the Board of Directors of the Indy Chamber of Commerce. He is also on the Board of Visitors for Duke’s Fuqua School of Business.

show morePrint Bio
Maria Crowe

Maria Crowe

President, Manufacturing Operations


Maria Crowe is the president of manufacturing operations for Eli Lilly and Company.

Maria joined Lilly in 1982 and since 2012 has led the company’s global manufacturing network of more than 20 sites on five continents. She also has responsibility for Lilly's contract-manufacturing organization.

Previously, Maria was senior vice president for global drug product manufacturing, which included emerging markets manufacturing, external drug-product operations, and U.S. distribution. She also served as vice president for drug product manufacturing in the U.S. and Latin America; general manager of Lilly’s plant in Kinsale, Ireland; general manager of Lilly del Caribe in Puerto Rico; and plant manager of the company’s Elanco plant in Tippecanoe. Maria’s roles have also included working in dry products, parenteral products, and API manufacturing, as well as in sourcing and procurement.

Maria holds a bachelor's degree in industrial management from Purdue University.

In addition to serving on Purdue's Krannert School of Management Dean's Advisory Council, Maria also serves as an advisory board member of Indianapolis Downtown, Inc.

show morePrint Bio
Stephen F. Fry

Stephen F. Fry

Senior Vice President, Human Resources and Diversity


Steve Fry is senior vice president, human resources and diversity, for Eli Lilly and Company.

Since joining Lilly in 1987 as a scientific systems analyst in Lilly Research Laboratories, Steve has held a range of roles in information technology and human resources. Following a series of managerial assignments, Steve served as human resources director for Lilly’s U.K. affiliate and then as executive director of human resources for the U.S. affiliate. In 2004 he was named managing director of the Australian affiliate, returning to the U.S. in 2007 to provide HR leadership for the global sales and marketing organization before accepting the role of vice president supporting the Lilly Bio-Medicines and Emerging Markets business units. He assumed his current role in 2011.

Steve earned his bachelor’s degree in information systems from the University of Indianapolis.

Steve serves on the board of trustees at the University of Indianapolis and the governance board for Make-A-Wish in Ohio, Kentucky, and Indiana.

show morePrint Bio
Michael J. Harrington

Michael J. Harrington

Senior Vice President and General Counsel


Mike Harrington is senior vice president and general counsel for Eli Lilly and Company.

Since joining Lilly in 1991 as an attorney in product liability litigation, Mike has served in a number of other business and legal positions, including managing director of the New Zealand affiliate and as associate general counsel for Lilly’s operations in the Asia-Pacific region. Mike most recently held the role of vice president and deputy general counsel of global pharmaceutical operations. In this capacity, he was responsible for legal issues related to Lilly’s five global business units.

Before joining Lilly, Mike was a litigator at the law firm of Baker & Daniels in Indianapolis.

Mike earned a bachelor’s degree in English from Albion College and a law degree from the Columbia University School of Law.

Mike currently serves on the boards and executive committees of the Indiana Chamber of Commerce, Lawyers for Civil Justice, and the Indiana Repertory Theatre. He is also a member of the board of trustees and executive committee of Albion College, and a member of the board of the International School of Indiana.

show morePrint Bio
Jan M. Lundberg, Ph.D.

Jan M. Lundberg, Ph.D.

Executive Vice President, Science and Technology,

and 
President, Lilly Research Laboratories


Jan Lundberg is executive vice president for science and technology and president of Lilly Research Laboratories (LRL).

Jan joined Lilly in 2010 as the leader of LRL, encompassing Research and the Medicines Development Unit. Before that he served for ten years as global head of discovery research at AstraZeneca, where he was a member of the senior executive team. He was involved with numerous candidate drug nominations, development projects, and marketed-product support, as well as in-licensing, partnering, and acquisitions.

In other previous roles, Jan served as a professor at the Karolinska Institute’s department of pharmacology in Stockholm, Sweden. He has 500 scientific publications and is a highly cited scientist with several recognition awards. He is a co-founder of Aerocrine AB, a biotech diagnostic company with exhaled nitric oxide as allergic asthma breath test.

Jan earned a BSM equivalent in medicine from the University of Gothenburg and a Ph.D. in pharmacology from Karolinska Institute in Stockholm, Sweden. He was also appointed as honorary doctor of Uppsala University’s pharmaceutical faculty.

Jan has served as chairman of the Ph.D. and post-doctoral program at the Karolinska Institute; on the evaluation committee for the Swedish Medical Research Council; on the executive advisory board of the Swedish Medical Products Agency Registration of New Drugs (affiliated with the European Medicines Agency); and as part of lead that generated the Innovative Medicines Initiative, a major public-private partnership in the European Union and recently the Accelerating Medicines Partnership with the NIH in the U.S. He serves on the boards of TransCelerate Biopharma, Inc., Pharma Foundation and the Indiana life-sciences initiative BioCrossroads.

show morePrint Bio
Susan Mahony, Ph.D.

Susan Mahony, Ph.D.

Senior Vice President and President, Lilly Oncology


Sue Mahony is a senior vice president of Eli Lilly and Company and president of Lilly Oncology.

Sue joined Lilly in 2000 after more than ten years in sales and marketing roles in the United Kingdom and Europe in oncology, hematology, and cardiovascular medicine for Schering-Plough, Amgen, and Bristol-Myers Squibb. At Lilly, Sue has worked in product development, Six Sigma, marketing, and general management roles. After leading Lilly’s operations in Canada, Sue was appointed senior vice president of human resources and diversity, before assuming her current role in 2011.

Sue earned a bachelor’s degree in pharmacy from Aston University in the U.K., and a Ph.D. in pharmacy in Aston’s Cancer Research Campaign’s experimental chemotherapy group. She also earned a master’s degree in business administration from the London Business School. In 2012, Sue received an honorary doctorate from Aston University.

Sue serves on the board of the United Way of Central Indiana.

show morePrint Bio
Barton R. Peterson

Barton R. Peterson

Senior Vice President, Corporate Affairs and Communications


Bart Peterson is senior vice president of corporate affairs and communications for Eli Lilly and Company.

Before joining Lilly in 2009 in his current role, Bart served as managing director of Strategic Capital Partners, as a fellow with the Institute of Politics at Harvard University’s Kennedy School of Government, and as a distinguished visiting professor of public policy at Ball State University. He continues as a fellow with Ball State’s Bowen Center for Public Affairs.

From 2000 to 2007, Bart served two terms as mayor of Indianapolis, and in 2007 was president of the National League of Cities. In conjunction with Indiana University, Purdue University, Lilly, and the Central Indiana Corporate Partnership, Bart championed the creation of BioCrossroads, the Indiana life-sciences initiative. Prior to running for office, he was a member of Indiana Governor Evan Bayh’s leadership team, first as his advisor for environmental affairs and later as chief of staff. He also was an attorney with IceMiller in Indianapolis.

Bart earned his bachelor’s degree from Purdue University and a law degree from the University of Michigan.

Bart is a founding member and board chair of The Mind Trust, a non-profit organization promoting education reform. He also is a board member of the Regenstrief Foundation, Christian Theological Seminary, and Kite Realty Group. In 2012, Bart was appointed by the U.S. Department of State to the Asia-Pacific Economic Cooperation (APEC) Business Advisory Council.

show morePrint Bio
Derica W. Rice

Derica W. Rice

Executive Vice President, Global Services,

and Chief Financial Officer


Derica Rice is executive vice president of global services and chief financial officer for Eli Lilly and Company.

After joining Lilly in 1990 as an international treasury associate, Derica served in a variety of roles, including sales representative, manager of global financial planning and analysis for the medical devices division, and global planning manager for pharmaceuticals. He then became finance director and chief financial officer for Lilly Canada, after which he was named executive director and chief financial officer for European operations based in London. Derica next served as general manager of Lilly’s U.K. affiliate and then as Lilly’s vice president and controller until he was promoted to CFO in 2006.

Derica earned a bachelor's degree in electrical engineering from Kettering University and a master's degree in business administration from Indiana University.

He serves as a member of the board of directors for Target Corporation, IU Health North, and the Center for Leadership Development. He also serves as a member of the Indiana University Board of Trustees and the Indianapolis Museum of Art’s Board of Governors.

show morePrint Bio
David A. Ricks

David A. Ricks

Senior Vice President

and President, Lilly Bio-Medicines


Dave Ricks is senior vice president of Eli Lilly and Company and president of Lilly Bio-Medicines.

After joining Lilly in 1996 as a business development associate, Dave held several management roles in U.S. marketing and sales before moving to Lilly Canada, where he served as director of pharmaceutical marketing, as national sales director, and then as general manager. He then was named president and general manager of Lilly China before becoming president of Lilly USA in 2009. Dave now leads Lilly Bio-Medicines, which encompasses the therapeutic areas of neuroscience, cardiovascular, urology, musculoskeletal, and autoimmunity, as well as the company’s global marketing and pricing, reimbursement, and access functions.

Before joining Lilly, Dave worked for Hewlett-Packard and IBM.

Dave earned a bachelor’s degree in business from Purdue University and a master’s degree in business administration from Indiana University.

Dave serves on the Board of Governors for the Riley Children’s Foundation.

show morePrint Bio
Jeffrey N. Simmons

Jeffrey N. Simmons

Senior Vice President and President, Elanco Animal Health


Jeff Simmons is a senior vice president of Eli Lilly and Company and president of Elanco Animal Health.

Since joining Lilly in 1989, Jeff has held a number of sales, marketing, and management positions in Elanco, including country director in Brazil and area director for Western Europe based in the United Kingdom. He was named president of Elanco in 2008.

Jeff earned a bachelor’s degree in business from Cornell University.

Jeff serves on the board of directors for Chiquita and serves as chairman of the International Federation of Animal Health.

show morePrint Bio
Fionnuala M. Walsh, Ph.D.

Fionnuala M. Walsh, Ph.D.

Senior Vice President, Global Quality


Fionnuala Walsh is senior vice president of global quality for Eli Lilly and Company.

Fionnuala joined Lilly in 1988 at the manufacturing site in Kinsale, Ireland, where she held roles in technical services, project outsourcing, new-product introductions, and laboratory analytics. Fionnuala also held management positions in quality and manufacturing science and technology before she was appointed global quality leader in 2002 and vice president for global quality operations in 2005. She has served as senior vice president of global quality since 2007.

Fionnuala earned her bachelor’s and doctoral degrees in chemistry from University College in Dublin, Ireland.

She has served as a member of the Irish Council for Science, Technology, and Innovation and the API Committee of the Pharmaceutical Researchers and Manufacturers of America (PhRMA).

show morePrint Bio
Alfonso G. Zulueta

Alfonso G. Zulueta

Senior Vice President and President, Emerging Markets


Alfonso "Chito" Zulueta is a senior vice president of Eli Lilly and Company and president of Lilly Emerging Markets.

After joining Lilly in 1988 in the Philippines, Chito held several sales and marketing positions in the U.S. before becoming general manager of the Philippines affiliate in 1995. He also served as vice president of global marketing, as vice president for diabetes, family health, and neuroscience products for the U.S. operations, and as president of the company’s Asian operations before becoming president of Lilly Japan in 2008.

Chito received a bachelor's degree in economics from DeSalle University in the Philippines and a master’s degree in business administration from the University of Virginia.

He has chaired the Japan-based executive committee of the Pharmaceutical Researchers and Manufacturers of America (PhRMA), and he serves on the boards of the American Chamber of Commerce in Japan and U.S.-Japan Business Council.

show morePrint Bio